The DOI matches its Crossref record; 11 of the 12 references it cites were found in a registry or an index.
Genetic Variants of SARS-CoV-2—What Do They Mean?
Open accessAbstract
This Viewpoint discusses emerging genetic variants of SARS-CoV-2, including new “UK” and “mink” variants and the significance of the new variants to coronavirus transmissibility, spread, virulence, and efforts to vaccinate the population against COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although circulating antibodies derived from plasma cells wane over time, long-lived immune memory can persist in expanded clones of memory B cells7,20.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Spike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans
Munnink, B. B. O., Sikkema, R. S., Nieuwenhuijse, D. F., Molenaar, R. J., Münger, E., Molenkamp, R., van der Spek, A. N., Tolsma, P., Rietveld, A., Brouwer, M., et al. (2020) · Science · doi:10.1126/science.abe5901 · Cited by 1,116
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.012 · Cited by 324
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityPreprint
Volz, E., Hill, V., McCrone, J., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20166082 · Cited by 313
We shouldn’t worry when a virus mutates during disease outbreaks
Grubaugh, N. D., Petrone, M. E., & Holmes, E. C. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0690-4 · Cited by 168
Cited by
Sorted by citations
Items 501–585 of 585
SARS-CoV-2 variant VUI 202012/01 (B.1.1.7) in a pediatric patient: first case report in Ecuador
Acosta-España, J. D., Arnao, A., Ramos, I. P. V., Espinoza, R. E. A., & Castro, Á. F. D. D. (2021) · Revista Ecuatoriana de Pediatría · doi:10.52011/0100
Update 2021: COVID-19 aus Sicht der Infektiologie
Khatamzas, E., & Kroidl, I. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1449-4964
Should RECOVERY have used Response Adaptive Randomization? Evidence from a simulation studyPreprint
Sirkis, T., Bowden, J., & Jones, B. (2021) · Research Square · doi:10.21203/rs.3.rs-814621/v2
Network analysis outlines strengths and weaknesses of emerging SARS-CoV-2 Spike variantsPreprint
Manrique, P. D., Chakraborty, S., Nguyen, K., Mansbach, R. A., Korber, B., & Gnanakaran, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.03.458946
COVID-19: A HEALTH PERSPECTIVE
Wong, S. X., EN, G. J., & Koh, D. S. Q. (2021) · Journal of Business & Economic Analysis · doi:10.1142/s2737566821500018
Delgado, R. B. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/s01.13.2021
Coronavirus Variants of Concern: An Insight
Mandal, P. K., Andrews, T., Bisbee, Q., Cheek, A., Davis, D., Harvey, J., Hayes, A., Hopkins, S., Mack, J., Narcisse, G., et al. (2021) · Biomedical Research and Clinical Reviews · doi:10.31579/2692-9406/080
Using Deep Learning Sequence Models to Identify SARS-CoV-2 DivergencePreprint
Ding, Y., Kuang, Z., Pei, Y., Tan, J. S., Zhang, Z., & Konan, J. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2111.06593
Sarsanti, A. S. N., Azzahra, A. S., Rahman, A., ghiyaats, A., Rahmadhanie, A. K., & Hidayaturrahmah, A. N. (2021) · doi:10.31219/osf.io/m8ahe
"The Deadly COVID-19 Being in Pandemic Near Two Years may be Man-Made in Inhumanity"
Han–You, X. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.40.006410
Banada, P. P., Green, R., Banik, S., Streck, D. L., Montalvan, I., Reiss, R., Jones, R., Marras, S. A. E., Chakravorty, S., & Alland, D. (2022) · medRxiv · doi:10.1101/2022.01.18.22269424
Marginal cost of multiple nomenclature conventions for SARS-CoV-2 variants (Preprint)Preprint
Zhi, H., Huang, Z., Hu, Q., Liu, M., & Jiang, H. (2021) · doi:10.2196/preprints.30421
Omicron! Alert for Dental Surgeons
Balaji, S. (2021) · Indian Journal of Dental Research · doi:10.4103/ijdr.ijdr_5_22
Idowu, A. O. (2022) · Texila international journal of public health · doi:10.21522/tijph.2013.10.01.art018
Call for a Global Vaccine Plan to Combat Current and Future Pandemics: One for ALL and ALL for One
Surani, S., Taweesedt, P. T., Surani, S. S., Ratnani, I., & Varón, J. (2022) · The Open Respiratory Medicine Journal · doi:10.2174/18743064-v16-e2202040
Epidemic trends of SARS-CoV-2 associated with immunity, race, and viral mutationsPreprint
Kamikubo, Y., Hattori, T., & Takahashi, A. (2021) · doi:10.33774/coe-2020-lkc5b-v5
The The More Precise, the Higher Eff icient
Puttawibul, P. (2021) · PSU Medical Journal · doi:10.31584/psumj.2021249405
Should RECOVERY have used Response Adaptive Randomization? Evidence from a simulation studyPreprint
Sirkis, T., Bowden, J., & Jones, B. (2021) · Research Square · doi:10.21203/rs.3.rs-814621/v1
Evolving Faces of SARS-CoV-2 with the Emergence of Diverse Variants
Tilak, R. (2022) · JOURNAL OF COMMUNICABLE DISEASES · doi:10.24321/0019.5138.202260
Two years of COVID-19: Challenges, opportunities and the way forward
Sharma, P., & Chauhan, G. (2022) · Indian Journal of Microbiology Research · doi:10.18231/j.ijmr.2022.020
Predicting the Disease Severity of Virus Infection
Qi, X., Shen, L., Chen, J., Shi, M., & Shen, B. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8969-7_6
Whole Genome Sequencing for Outbreak Investigation
Chiang, A. D., & Palmore, T. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-98427-4_20
Overview of coronavirus pandemic
Sainz, L. A., Ibáñez-Navarro, A., Morante‐Ruiz, M., Bilbao, J. S.-V., Tapetado, G. R. D. L., Sarría‐Santamera, A., & Quintana‐Díaz, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91172-6.00013-3
Precision medicine in COVID-19 patients
Tomo, S., Batra, J., & Aggarwal, J. (2022) · Santosh University Journal of Health Sciences · doi:10.4103/sujhs.sujhs_8_22
Uncovering hidden sources of SARS‐CoV‐2 viral evolution: A call to action
Choudhary, M. C., & Li, J. Z. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13910
Perspective Chapter: Tracking Trails of SARS CoV-2 – Variants to Therapy
Kumar, A., Pai, M. O., Badoni, G., Singh, A., Agrawal, A., & Omar, B. J. (2022) · Infectious diseases · doi:10.5772/intechopen.106472
Roriz, N. F., Ribolis, I. P., dos Santos, J. M., Pereira, H. M. D. V., Bogo, D., Tognini, J. R. F., & Guimarães, R. D. C. A. (2022) · Research Society and Development · doi:10.33448/rsd-v11i12.31965
Çakır, A., Şener, K., Karabulut, N., Arslan, B., Altuğ, E., Eyüpoğlu, G., & Güven, R. (2022) · Global Emergency and Critical Care · doi:10.4274/globecc.galenos.2022.35229
Importancia de la vigilancia genómica de SARS-CoV-2 en los tiempos de las vacunas contra la COVID-19
Jones-Cifuentes, N. A., Peña-López, B. O., & Rincón‐Orozco, B. (2022) · Salud UIS · doi:10.18273/saluduis.54.e:22058
Rony, M. K. K., Hasan, N., Chowdhury, S., & Rahman, I. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-23828-6
SARS-COV-2 ՎԱՐԱԿ. ԱՌՈՂՋԱՊԱՀԱԿԱՆ ՆՈՐ ՄԱՐՏԱՀՐԱՎԵՐ (ԱԿՆԱՐԿ)
Ղազարյան, Ա. Գ. (2022) · MEDICINE SCIENCE AND EDUCATION · doi:10.56936/18291775-2022.33-29
Cabrera, M., Salazar-Viedma, M., & D’Afonseca, V. (2022) · Genetics and Molecular Research · doi:10.4238/gmr19003
Rapid System to Detect Variants of SARS-CoV-2 in Nasopharyngeal Swabs
Favaro, M., Zampini, P., Pistoia, E. S., Gaziano, R., Grelli, S., & Fontana, C. (2023) · Viruses · doi:10.3390/v15020353
The SARS-CoV-2 variants around us: A literature review
Aloysius, D. C., & Siswati, B. H. (2023) · Malaysian Journal of Microbiology · doi:10.21161/211389
Wachter, J. K., Cadamuro, R. D., Savi, B. P., Elois, M. A., Pilati, G. V. T., de Souza, E. B., Padilha, D. A., Rodrigues, M. V. D., Rossi, E. M., Malutta, S., et al. (2023) · Instituto de Inteligência em Pesquisa e Consultoria Cientifica Ltda eBooks · doi:10.56041/9786599841835-4
COVID-19: Imunopatologia e danos teciduais
Klinkonsky, F. V., Vieira, A. B., & Besson, J. C. F. (2023) · Research Society and Development · doi:10.33448/rsd-v12i3.40491
The molecular basis of the severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
Al-Othman, N., Rabayaa, M., & Ghanim, M. A. (2022) · Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal · doi:10.59049/2790-0231.1094
Medical Perspective on COVID-19
Hosseini-Nezhad, P., Hosseini-Nezhad, S., & Hosseini-Nezhad, A. (2023) · Contributions to economics · doi:10.1007/978-3-031-27886-0_2 · Cited by 1
SARS-CoV-2 Virüsünün Yapısı ve Virolojik Özellikleri
Toptan, H., & Köroğlu, M. (2023) · doi:10.59537/saupress.2302
Vigilancia de variantes genéticas del virus SARS-CoV-2 en la Frontera Sur de México
Lugo‐Trampe, Á., Joo-Domínguez, A. D. J., Pérez, P. M., Cruz, L. I. G., Arévalo, F. O. P., Espinoza-Ruiz, M., Chang-Rueda, C., & Trujillo-Murillo, K. D. C. (2023) · Revista Mesoamericana de Investigación · doi:10.31644/rmi.v3n3.2023.a01
Multiplex qPCR Discriminates Variants of Concern to Enhance Global Surveillance of SARS-CoV-2
Vogels, C. B. F., Breban, M. I., Ott, I. M., Alpert, T., Petrone, M. E., Watkins, A. E., Kalinich, C. C., Earnest, R., Rothman, J. E., de Jesus, J. G., et al. (2023) · doi:10.1201/9781003298038-30
Self-citationSARS-CoV-2 (COVID-19) Variants in Mexico
Pérez-Arenas, L. U., Plascencia-Roldán, J. P., Morales-Reyes, G. I., Flores-Vargas, G., Gallardo-Luna, M. D. J., Navarro-Olivos, E., Magos-Vázquez, F. J., & Padilla-Raygoza, N. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002400
Saha, S., Majumdar, S., & Bhattacharyya, P. (2023) · Springer eBooks · doi:10.1007/978-981-99-3505-5_11
Tracking SARS-CoV-2 variants in Kurdistan Region of Iraq.
Mohamedsalih, P. M., Salih, K. J., Kareem, B. O., & Sabir, D. K. (2023) · ZANCO Journal of Pure and Applied Sciences · doi:10.21271/zjpas.35.5.12
Notable variants of SARS COV 2 Virus - A Mini-Review
Lawani-Luwaji, E. U., Alade, T., & John, B. U. (2023) · African Journal of Biology and Medical Research · doi:10.52589/ajbmr-eo2rwpkp
Modeling and analyzing COVID-19 infections in South Africa
Song, T., Wang, Y., Wang, C., & An, Q. (2023) · International Journal of Biomathematics · doi:10.1142/s1793524523501036
Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes
Boon, W. X., Sia, B. Z., & Ng, C. H. (2024) · F1000Research · doi:10.12688/f1000research.72896.3
Distribution of SARS-CoV-2 Variants in West Java Based on Genomic Surveillance Data, 2021-2022
Alamanda, C. N. C., Parwati, I., Pradani, G. A. P., & Fibriani, A. (2024) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v30i3.2209
Data-Driven Methods for Viral Variants’ Identification
Bernasconi, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00087-7
Phylogenetic analysis of SARS-CoV-2 in COVID-19 samples from intibios lab Semarang
Herida, A. P., Kusumaningrum, H. P., Ferniah, R. S., Budiharjo, A., & Pujiyanto, S. (2024) · AIP conference proceedings · doi:10.1063/5.0215808
SARS-CoV-2: Mapping its features that made it as a unique virus
Amara, A. A. A. F. (2023) · Environment and Public Health Research · doi:10.59400/ephr.v1i1.490
Pathogenesis and Clinical Research Progress of COVID-19
Zheng, C. (2024) · BIO Web of Conferences · doi:10.1051/bioconf/202412402007
Plackowski, K., Ebinumoliseh, I., Ogbuewu, E., Hoff, K., & Edwards, J. S. (2024) · Research Square · doi:10.21203/rs.3.rs-4999540/v1
Akter, S., Zeba, Z., Hossain, M. A., Ofori, M. A., Shahab, M., Silva, G. V. R., Oliveira, J. I. N., Akash, S., Banu, T. A., Islam, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.25.620187
Bartkowiak, E., Rozwadowska, B., Albertyńska, M., Miara, A., & Hudzik, G. (2025) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0054.9880
SIRT2 protects against Japanese encephalitis virus infection in micePreprint
Desingu, P. A., Dindi, L., Murugasamy, K., Tamta, A. K., Ramasubbu, V., Raghu, S., Shrama, A., Rajmani, R. S., & Sundaresan, N. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.24.645101
Viral Infections of the Nervous System
Bonthius, D. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00134-7
COVID-19 Vaccines Development: Challenges and Future Perspective
Chowdhury, S. K., Mridha, N. K., Khan, A. A., Baildya, N., Mandal, M., & Ghosh, N. N. (2025) · International Journal of Clinical Virology · doi:10.29328/journal.ijcv.1001064
Bio-Genetics and Disease: Diagnostic and Analytical Approaches
Juma, M., Jasab, S. J. H., Mohammed, S. H. H., & Alai, L. H. S. (2025) · Bright Sky Publications eBooks · doi:10.62906/bs.book.388
SIRT2 protects against Japanese encephalitis virus infection in micePreprint
Desingu, P. A., Dindi, L., Murugasamy, K., Tamta, A. K., Ramasubbu, V., Raghu, S., Shrama, A., Rajmani, R. S., & Sundaresan, N. R. (2025) · eLife · doi:10.7554/elife.106778.1
SIRT2 protects against Japanese encephalitis virus infection in micePreprint
Desingu, P. A., Dindi, L., Murugasamy, K., Tamta, A. K., Ramasubbu, V., Raghu, S., Shrama, A., Rajmani, R. S., & Sundaresan, N. R. (2025) · eLife · doi:10.7554/elife.106778
Predicting and Modelling the Spread of COVID-19 Variants in the USA: A Time-Varying SEIRVHD Approach
Sabherwal, A. K., & Sood, A. (2024) · International Conference on Advances in Computing, Communication and Materials (ICACCM) · doi:10.1109/icaccm61117.2024.11059192
Variant Delta au Canada : ses origines, ses points chauds et sa résistance aux vaccins
Kindrachuk, J., & Shaw, S. Y. (2021) · doi:10.64628/aap.d5x7rsh3x
COVID-19 as an Emerging Infectious Disease and its Variants
Aziz, M., Shah, A., Qayyum, R., Nawaz, S., Arif, I., Ali, M., Hassan, M. S., Ali, R., & Omar, H. (2025) · Coronaviruses · doi:10.2174/0126667975397588250818115346
The evolutionary battle: data-driven analysis of SARS-CoV-2 virulence
Yin, K., Wang, Y., & Meng, X. (2025) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2025.2582765
Akinde, S. B., Oyedara, O. O., Olumakinde, T. S., Olaniyan, O. P., Adeyemi, F. M., Bolarinwa, R. A., Adeagbo, O. Y., Oluokun, T. E., Sule, W. F., Ojo, O. O., et al. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02286-2
Sirkis, T., Jones, B., & Bowden, J. (2022) · Figshare · doi:10.6084/m9.figshare.20445360
Additional file 1 of Precision therapeutic targets for COVID-19
Krumm, Z. A., Lloyd, G. M., Francis, C. P., Nasif, L. H., Mitchell, D. A., Golde, T. E., Giasson, B. I., & Xia, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14337691
Ye, L., Hu, M., YUAN Ye, W. C., Li, Z., Cun, Y., Tang, K., & Cao, Z. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1692727
Characterization of Mutational Clusters in the N-Terminal Domain of SARS-CoV-2 Spike Protein
Saber, N., & Kandala, N. J. (2026) · Iraqi Journal of Science · doi:10.24996/ijs.2026.67.3.15
Seroepidemiology of emerging viruses in Bolivia
Jordan, L. I. (2023) · theses.fr (ABES) · doi:10.70675/1070f335z49aaz4d85zb796z713dd35bc6fc
Mziou, E., Hchaichi, A., Letaief, H., Dhaouadi, S., Safer, M., Mhadhbi, R., Osman, M., Talmoudi, K., Zouayti, A., Oumaima, K., et al. (2026) · COVID · doi:10.3390/covid6080133
Foxman, B., & Manning, S. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21471-4.00011-6
Mohamed, M. I. A., Lee, J.-P., Shin, W.-R., Park, D., Oh, I.-H., Lee, S.-M., Min, J., Ahn, J., & Kim, Y.-H. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103112
Codon Mutation Probability Modeling in SARS-CoV-2
Thakur, S. K., Nizam, A. A., & Robert, N. J., V (2026) · IEEE Access · doi:10.1109/access.2026.3734209
Liu, X., Liao, W., Chen, S., Wang, X., & Lu, G. (2026) · Veterinary Microbiology · doi:10.1016/j.vetmic.2026.111232
SIRT2 protects against Japanese encephalitis virus infection in micePreprint
Desingu, P. A., Dindi, L., Murugasamy, K., Tamta, A. K., Ramasubbu, V., Raghu, S., Shrama, A., Rajmani, R. S., & Sundaresan, N. R. (2026) · eLife · doi:10.7554/elife.106778.2
Metadata
- Authors
- Lauring, A. S., & Hodcroft, E. B.
- Affiliations
- University of Michigan (US)
- University of Bern (CH)
- Corresponding author
- Lauring, Adam S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-02-09
- Volume
- 325
- Issue
- 6
- Pages
- 529
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3119231619
- Cited by
- 604
- References
- 12
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 39 · 2023: 72 · 2022: 197 · 2021: 264
- FWCI
- 45.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- JAMA (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- SARS-CoV-2, genetic variants, UK variant, COVID-19 pandemic, transmissibility, virulence, COVID-19 vaccination, viral evolution
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Animals, Humans, Mink, Mutation, Phylogeny, Genetic Variation, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review